share_log

T2 Biosystems | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nathan D. Hukill(65.4%),CR Group L.P.(65.4%), etc.

SEC announcement ·  May 8 07:51
Summary by Futu AI
In a recent filing with the United States Securities and Exchange Commission, Nathan D. Hukill, along with associated entities including CR Group L.P. and various CRG Partners funds, reported a significant change in their beneficial ownership of T2 Biosystems, Inc. The group now collectively owns 8,853,173 shares, representing approximately 65.4% of the company's issued and outstanding common stock. This change in ownership is a result of the cancellation of outstanding loans to T2 Biosystems by the reporting entities, as detailed in the amended Schedule 13D filed on May 7, 2024. The loans were originally part of a Term Loan Agreement dated December 30, 2016. The most recent acquisitions of shares by the group occurred on April 12 and May 3, 2024. The filing indicates that no other transactions in the common stock have been made by the reporting persons in the last 60 days.
In a recent filing with the United States Securities and Exchange Commission, Nathan D. Hukill, along with associated entities including CR Group L.P. and various CRG Partners funds, reported a significant change in their beneficial ownership of T2 Biosystems, Inc. The group now collectively owns 8,853,173 shares, representing approximately 65.4% of the company's issued and outstanding common stock. This change in ownership is a result of the cancellation of outstanding loans to T2 Biosystems by the reporting entities, as detailed in the amended Schedule 13D filed on May 7, 2024. The loans were originally part of a Term Loan Agreement dated December 30, 2016. The most recent acquisitions of shares by the group occurred on April 12 and May 3, 2024. The filing indicates that no other transactions in the common stock have been made by the reporting persons in the last 60 days.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.